We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fluorescence Optical Imaging Technology

By Biotechdaily staff writers
Posted on 29 Aug 2003
A new fluorescence optical imaging technology allows in vivo imaging of molecular processes, which is expected to speed the research and development of new drugs.

The technology, called bonSAI, is designed to aid drug-target identification and early prioritization of candidate compounds, speeding research and decreasing time to market. More...
Molecular imaging allows noninvasive measurement of molecular and biologic processes, probing the molecular abnormalities that are the origin of disease rather than imaging the resulting conditions caused by the disease.

The technology was developed by Siemens Medical Solutions (Erlangen, Germany) in collaboration with Dr. Ralph Weissleder, M.D., Ph.D, director of the Center for Molecular Imaging Research at Massachusetts General Hospital (MGH, Boston, USA). The bonsai technology also has broad applications in basic academic research at an affordable price, states Siemens.

"The adaptation of fluorescent optical techniques to diagnostic imaging is now changing the way we visualize molecular processes in vivo and ultimately, in the clinic,” said Dr. Weissleder.





Related Links:
Siemens Medical

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
POC Immunoassay Analyzer
Procise DX
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.